CellSource: [Postponed] Earnings conference for the second quarter of the October 2024 fiscal year.
CellSource: Confirmation letter
CellSource: Quarterly Report - 2nd Quarter of the 9th period (February 1, 2024 - April 30, 2024)
CellSource: Financial results presentation materials for the second quarter of fiscal year ending October 2024.
CellSource: 2Q fiscal year 2024 financial results announcement [Japan GAAP] (non-consolidated)
CellSource: [Summary] Non-consolidated financial statements for the six months ending on April 30, 2024 (based on Japanese accounting standards).
CellSource: Corporate Governance Report 2024/05/01
CellSource: Anicom Animal Hospital Group launches platelet-derived growth factor therapy for dogs
CellSource: Cell source “Egg Freezing Security Bank” service adopted as C&R's welfare system
Cell Source: Notice Concerning Determination of the Details of Issuance of Stock Acquisition Rights to Outside Collaborators
Cell Source: Change Report
Cell Source: Change Report
Cell source: confirmation
Cell Source: Quarterly Report - 9th Quarter (2023/11/01 - 2024/01/31)
Cell source: Summary of financial results for the 1st quarter of the fiscal year ending 2024/10 [Japanese GAAP] (unconsolidated)
Cell Source: Adipose-Derived Stem Cell/Blood-Derived Processing Contract Service Technology Update Notice
Cell Source: Cell Source “Egg Freezing Security Bank” service adopted as a welfare system for LIFE CREATE
Cell source: Financial results presentation materials for the 1st quarter of the fiscal year ending 2024/10
Cell source: Unconsolidated financial results for the three months ended January 31, 2024 (based on Japanese accounting standards)
Cell Source: Notice of granting share transfer reservation rights from major shareholders to the President and CEO
No Data